Clinical Trial Update: Bioinformation Therapy for Pancreatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of Phase 2 and Phase 3 testing of a bioinformation therapy for unresectable pancreatic cancer. The trial is sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bioinformation Therapy

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Unresectable Pancreatic Cancer | Phase 2, Phase 3 | Status: COMPLETED